Cargando…

Metabolic Intermediates in Tumorigenesis and Progression

Traditional antitumor drugs inhibit the proliferation and metastasis of tumour cells by restraining the replication and expression of DNA. These drugs are usually highly cytotoxic. They kill tumour cells while also cause damage to normal cells at the same time, especially the hematopoietic cells tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yuchen, Gao, Menghui, Tang, Haosheng, Cao, Yiqu, Liu, Shuang, Tao, Yongguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567815/ https://www.ncbi.nlm.nih.gov/pubmed/31223279 http://dx.doi.org/10.7150/ijbs.33496

Ejemplares similares

cGAS/STING: novel perspectives of the classic pathway
por: Gao, Menghui, et al.
Publicado: (2020)

Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing
por: Lai, Weiwei, et al.
Publicado: (2017)

Chromatin remodeling factor lymphoid-specific helicase inhibits ferroptosis through lipid metabolic genes in lung cancer progression
por: Jiang, Yiqun, et al.
Publicado: (2017)

Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
por: Zhang, Ziying, et al.
Publicado: (2019)

The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression
por: Wu, Yuqing, et al.
Publicado: (2020)

PKM2: The Thread Linking Energy Metabolism Reprogramming with Epigenetics in Cancer
por: Chen, Ling, et al.
Publicado: (2014)

LSH interacts with and stabilizes GINS4 transcript that promotes tumourigenesis in non-small cell lung cancer
por: Yang, Rui, et al.
Publicado: (2019)

Succinate: An initiator in tumorigenesis and progression
por: Zhao, Ting, et al.
Publicado: (2017)

Metabolic Alterations in FMR1 Premutation Carriers
por: Cao, Yiqu, et al.
Publicado: (2020)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

The Role of DACT Family Members in Tumorigenesis and Tumor Progression
por: Zeng, Yu, et al.
Publicado: (2022)

Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis
por: Niu, Nan, et al.
Publicado: (2023)

The role of T-box genes in the tumorigenesis and progression of cancer
por: Chang, Fangyuan, et al.
Publicado: (2016)

Role of DKK4 in Tumorigenesis and Tumor Progression
por: Cai, Xinjia, et al.
Publicado: (2018)

Newly discovered mechanisms that mediate tumorigenesis and tumour progression: circRNA‐encoded proteins
por: Wu, Chengwei, et al.
Publicado: (2023)

The chromatin-associated RNAs in gene regulation and cancer
por: Tang, Jun, et al.
Publicado: (2023)

Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
por: Jin, Xiao, et al.
Publicado: (2020)

Sirtuins in metabolism, DNA repair and cancer
por: Mei, Zhen, et al.
Publicado: (2016)

Progress of Wnt Signaling Pathway in Osteoporosis
por: Gao, Yongguang, et al.
Publicado: (2023)

The Role of MicroRNAs in Bone Metabolism and Disease
por: Gao, Yongguang, et al.
Publicado: (2020)

Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis
por: Shi, Feng, et al.
Publicado: (2020)

Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma
por: Kanwore, Kouminin, et al.
Publicado: (2022)

Regulating tumor suppressor genes: post-translational modifications
por: Chen, Ling, et al.
Publicado: (2020)

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
por: Shunxi, Wang, et al.
Publicado: (2023)

Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
por: You, Mengshu, et al.
Publicado: (2023)

MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis
por: Tomasetti, Marco, et al.
Publicado: (2016)

Metabolic reprogramming: a bridge between aging and tumorigenesis
por: Drapela, Stanislav, et al.
Publicado: (2022)

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
por: Xu, Ye, et al.
Publicado: (2021)

The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development
por: Doocey, Claire M., et al.
Publicado: (2022)

Connecting Chromatin Modifying Factors to DNA Damage Response
por: Lai, Weiwei, et al.
Publicado: (2013)

Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
por: Peng, Xintong, et al.
Publicado: (2021)

The Nervous System Contributes to the Tumorigenesis and Progression of Human Digestive Tract Cancer
por: Dai, Dayou, et al.
Publicado: (2022)

The aldehyde hypothesis: metabolic intermediates as antimicrobial effectors
por: Darwin, K. Heran, et al.
Publicado: (2022)

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
por: Lad, Eleonora M., et al.
Publicado: (2023)

Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
por: Chen, Yifan, et al.
Publicado: (2021)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
por: Newman, David L., et al.
Publicado: (2019)

The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
por: Ruiz-Iglesias, Ainhoa, et al.
Publicado: (2021)

Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression
por: Wei, Zeyu, et al.
Publicado: (2022)

Current situation and progress of drugs for reducing intraocular pressure
por: Liu, Peiyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b725f8mq707t9g0bsoldimpfd9